$NVLX Headlines 10-Q: NUVILEX, INC. 6:07 a.m. Dec. 16,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$NVLX Headlines

10-Q: NUVILEX, INC. 6:07 a.m. Dec. 16, 2013 - Edgar Online - (EDG = 10Q, 10K)
Newly Transformed Nuvilex To Enjoy Strong 2014 11:33 a.m. Dec. 10, 2013 - Seeking Alpha
Nuvilex Names Kenneth L. Waggoner as President and CEO 9:18 a.m. Nov. 25, 2013 - benzinga.com
An Ongoing Debate: Is Nuvilex For Real? 2:19 p.m. Nov. 5, 2013 - Seeking Alpha
10-Q: NUVILEX, INC. 5:03 a.m. Sept. 16, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: NUVILEX, INC. 3:21 p.m. July 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: NUVILEX, INC. 5:14 a.m. March 26, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: NUVILEX, INC. 4:49 p.m. Dec. 26, 2012 - Edgar Online - (EDG = 10Q, 10K)

Nuvilex's Provides Progress Update on Cell Cloning Being Performed by Inno Biologics 9:30 a.m. Today - GlobeNewswire
Nuvilex to Answer Increasing Calls for Better Pancreatic Cancer Treatment Without Gemcitabine 9:15 a.m. Dec. 16, 2013 - Marketwire
Nuvilex's Preparations for Planned Late-Phase Clinical Trials Timely in Light of Increasing Incidence of Pancreatic Cancer 9:30 a.m. Dec. 12, 2013 - GlobeNewswire
Nuvilex's (NVLX) Acquisition of Cellulose-based Live-Cell Encapsulation Technology Positions Company as a Leader in Development of Next Generation Cancer and Diabetes Treatments 8:30 a.m. Dec. 12, 2013 - ACCESSWIRE
Nuvilex's Contractor, Inno Biologics, Employs Clone-Pix(TM) Technology in Cloning Cells for Future Clinical Trials 9:30 a.m. Dec. 11, 2013 - GlobeNewswire
Nuvilex Holds High Level Strategic Meetings to Solidify Company Objectives and Plans for Future Research and Development 9:30 a.m. Dec. 9, 2013 - GlobeNewswire
Nuvilex's Subsidiary, Medical Marijuana Sciences, Inc., Appoints Dr. Mark L. Rabe as Chairman of Its Scientific Advisory Board 9:30 a.m. Dec. 6, 2013 - GlobeNewswire
After Pancreatic Cancer, Eli Lilly and Nuvilex Could Battle Over Diabetes Treatment 9:15 a.m. Dec. 5, 2013 - Marketwire
Record Diabetes Cases Highlight Need for Nuvilex Treatment 8:45 a.m. Dec. 4, 2013 - Marketwire
Nuvilex Ahead of the Curve on Cannabidiol as FDA Issues Landmark Approval 8:30 a.m. Nov. 29, 2013 - Marketwire
Nuvilex Accelerates Development of Treatments for Cancer and Diabetes With New Corporate Management Structure 10:15 a.m. Nov. 25, 2013 - GlobeNewswire
Nuvilex's Acquisition of Diabetes Rights Should Put the Company on Everyone's Radar 8:31 a.m. Nov. 19, 2013 - Marketwire
Nuvilex: The Triple Threat 9:30 a.m. Nov. 13, 2013 - Marketwire
Detailed Coverage on NVLX, PGLO, LIFS and DROP 2:02 a.m. Nov. 13, 2013 - ACCESSWIRE
Investors Confidently Back Nuvilex's Acquisition of Diabetes Technology 8:45 a.m. Nov. 12, 2013 - Marketwire
In Depth Coverage on SEEK, NVLX, SGLB and LQMT 1:43 a.m. Nov. 11, 2013 - ACCESSWIRE
Nuvilex Advances Company Toward Future Clinical Treatments Through Successful Acquisition of Exclusive Worldwide Rights to Live-Cell Encapsulation Technology for Diabetes 10:30 a.m. Nov. 8, 2013 - GlobeNewswire
Nuvilex Completes Acquisition of Exclusive Worldwide Rights to Live-Cell Encapsulation Technology for Diabetes 9:30 a.m. Nov. 7, 2013 - GlobeNewswire
Detailed Insight on NVLX, ENIP, CBIS and FARE 1:20 a.m. Nov. 6, 2013 - ACCESSWIRE
Nuvilex, Inc. Reaches Unofficial Starting Line of Its Phase 3 Pancreatic Cancer Clinical Trials 8:30 a.m. Nov. 5, 2013 - Marketwire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Victory Gala Honors Heroes, Raises Over $500K

Updated Category News Views 41

A Night Celebrating Service and Sacrifice You know, in times like these, it’s refreshing to see events that focus on giving back rather than taking everything to the bank. Victory Home Remodeling, along with its nonprofit arm, the Victory Foundation, recently hosted their second annual gala in Woodland Park, New Jersey to give some much-needed limelight to those who put...

Continue Reading
Evotec SE to Release Q3 Results: What to Expect

Updated Category News Views 72

Anticipation Builds Around Evotec's Q3 2026 Results It's that time again when everyone's tightening their belts in anticipation of another earnings feed. On November 5, Evotec SE is dropping their results for the first nine months of this whirlwind year. Right out of Germany, Hamburg, they're gearing up for a webcast and conference call where all eyes, or should I say...

Continue Reading
AskGamblers Unveils Tool for Casino Complaints

Updated Category News Views 38

A Fresh Move in the Casino World AskGamblers has made a move that might just change the game for online bettors. They’ve rolled out a new casino complaints dashboard designed to revolutionize how players raise issues with casinos. Sure, the gambling world is no stranger to complaints, and it's about time someone in the sector paid attention to airing dirty laundry in a...

Continue Reading
Maison Martell Bridging Artistry: Davido Meets Prince Gyasi

Updated Category News Views 26

Maison Martell Dances to a New Beat The world's oldest cognac house, Maison Martell, is mixing things up in a way that’ll make your typical whiskey-on-the-rocks seem like child’s play. They've snagged Afrobeat heavyweight Davido and renowned visual poet Prince Gyasi to spin a fresh narrative, one where melody and imagery play in harmony. While this ain't your usual...

Continue Reading
SeaWorld Rings in Holidays with All-New Festivities

Updated Category News Views 47

Holiday Transformation at SeaWorld's Parks The holiday spirit isn't something you purchase—it’s an experience. And boy, SeaWorld seems to get this right. As the chill of late October settles in, SeaWorld parks across Orlando, San Diego, and San Antonio start dressing up for the holiday season, morphing into a spectacle of lights and festive joy. For anyone who’s...

Continue Reading
Motiva's Q3 2026 Results: Strategic Moves Drive Growth

Updated Category News Views 57

Strategic Transactions and Financial Highlights Motiva's third quarter of 2026 shows a company not just coasting but recalibrating its trajectory. Big moves had ripple effects on their financial landscape, most notably their sale of the Airport Platform, concluded for a hefty R$5.2 billion. Their portfolio's trimming isn't just a garage sale but a thought-out step...

Continue Reading
SKE Invigorates IRONWORKS London's Music Vibe With E-Cigs

Updated Category News Views 0

Bringing SKE's Flair to London's Music Scene Well, folks, hold onto your hats—SKE's thrown its weight behind IRONWORKS London, extending its reach deeper into the UK's electronic music scene. This ain't just another gig; we're talking about the second time SKE is flexing its sponsorship muscles in the UK music arena, officially angling for the vape category spotlight....

Continue Reading
Willis Automotive Changes Hands: A Deep Dive

Updated Category News Views 100

A Historic Shift in Iowa's Auto Dealership Landscape Shifts in ownership can be like the changing of the guard, and we've got a significant one unfolding in Iowa. Rich Willis, a stalwart of the dealership game, is passing the baton—not to just anyone, but to a duo with serious heritage in the industry: Jason Willis and Collin Sewell. The transaction sees Willis...

Continue Reading
Solink Secures $100M: NYSE Sees Tech and Sports Moves

Updated Category News Views 101

Folks, it’s a busy day on Wall Street, with Solink leading the charge by landing over a cool $100 million in fresh funding. Let's break this down because when startups pocket nine-digit figures, it's time to pay attention. Solink's Leap Forward Now, what’s Solink doing with all that cash? They're not scrambling for coffee money, that's for sure. Instead, this funding...

Continue Reading
Cerebras Faces Durability Allegations: Investor Alert

Updated Category News Views 47

Cracks in Cerebras' Processor Promises? When you dance with high-stakes tech stocks, sometimes you end up stepping on a few toes. This seems to ring true as Cerebras Systems (CBRS) dances its way into hot water. Allegations from Culper Research suggest their fancy AI processors, which are supposed to be the poster children of reliability, might bow out early. Digging...

Continue Reading

Top 5 Most Recently Viewed Articles

Is Wall Street Overestimating the Impact of Fed Rate Cuts?

Updated Category News Views 61

Wall Street’s Reaction to Recent Fed Rate Cuts Recently, the Federal Reserve has made significant adjustments to its monetary policy, leading to a wave of optimism on Wall Street. Jerome Powell's maneuvers have garnered attention as he appears to be responding to inflation concerns by potentially enacting further rate cuts. The market's reaction suggests that investors...

Continue Reading
Telix Pharmaceuticals Class Action Lawsuit Insights and Updates

Updated Category News Views 209

Understanding the Class Action Lawsuit Against Telix Pharmaceuticals In recent developments, Telix Pharmaceuticals Ltd. finds itself at the center of a class action lawsuit. This legal action serves to protect investors who may have suffered losses and seeks to hold the company accountable for its actions. The Role of The Gross Law Firm The Gross Law Firm has stepped in...

Continue Reading
Japanese Investors Drive Foreign Stock Purchases Amid Optimism

Updated Category News Views 590

Japanese Investors Amplify Foreign Stock Acquisitions Recent trends show that Japanese investors have significantly increased their investments in foreign stocks. This surge can be attributed to encouraging developments regarding U.S. core inflation. A recent report indicated a slight decrease in core inflation, which has ignited hopes for potential rate cuts by the...

Continue Reading
Tech Leaders Reinforce Investment in U.S. Economy During Summit

Updated Category News Views 190

Tech Giants Step Up Commitment to U.S. Investment In a recent gathering, prominent technology executives met to affirm their investments in the U.S. market. The White House hosted these tech leaders as they showcased their ambitious plans while aligning with regulatory goals aimed at enhancing business operations. Billion-Dollar Pledges From Major Companies At this...

Continue Reading
Indaptus Therapeutics Strengthens Global Patent Portfolio Efforts

Updated Category News Views 93

Indaptus Therapeutics Enhances Patent Protections Worldwide Indaptus Therapeutics, Inc. (Nasdaq: INDP), a forward-thinking biotechnology firm focused on innovative cancer therapies and viral infections, is proud to announce a significant expansion of its patent portfolio. This expansion secures vital approvals in key regions, including China, Japan, and Israel, for its...

Continue Reading